261969-05-5
261969-05-5 结构式
基本信息
H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH
Calcium-like peptide 3
Calcium-Like Peptide 3,CALP-3
L-Lysine, L-valyl-L-lysyl-L-phenylalanylglycyl-L-valylglycyl-L-phenylalanyl-
Calcium-Like Peptide 3 trifluoroacetate salt H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH trifluoroacetate salt
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/04/30 | HY-P1075 | H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH CALP3 | 261969-05-5 | 1mg | 550元 |
| 2024/04/30 | HY-P1075 | H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH CALP3 | 261969-05-5 | 5mg | 1700元 |
| 2024/04/30 | HY-P1075 | H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH CALP3 | 261969-05-5 | 10mg | 2500元 |
常见问题列表
|
Ca 2+
|
CALP3 (50, 100, 150, 200 μM) inhibits glutamate caused a large sustained increase in [Ca
2+
]
i
in a dose-dependent manner (IC
50
=37.25 μM) in Fura-2-loaded neuronal cultures.
CALP3 (50, 100, 150, 200 μM) inhibits glutamate-induced cytotoxicity in a dose-dependent manner (IC
50
=50.97 μM) in cultured rat neocortical neurons. CALP3 causes dose-dependent inhibition of apoptosis (IC
50
=33.41 μM).
CALP3 (100 μM) inhibits apoptosis induced by HIV gp120 and SAg in Human T cells.
CALP3 (100 μM; 15 min pretreatment) reduces gossypol-induced necrosis and increases the fraction of live cells.
Cyclic-CALP3 is synthesized starting from Fmoc-Asp(PEG-PS)-OAl. Cyclic CALP3 is unable to inhibit Ca21 influx, and this peptide served as a negative control. Cyclic CALP3 does not inhibit the effect of glutamate.